Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals

Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AAOHN journal 2018-06, Vol.66 (6), p.302-309
1. Verfasser: Surjadi, Miranda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 309
container_issue 6
container_start_page 302
container_title AAOHN journal
container_volume 66
creator Surjadi, Miranda
description Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.
doi_str_mv 10.1177/2165079917751479
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1990486898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2165079917751479</sage_id><sourcerecordid>2043539524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</originalsourceid><addsrcrecordid>eNp1kU1LAzEQhoMoVtS7Jwl48dDVZDefx1I_oeBBPS9pdramtNmaZAv-e1PaKgjOZYbM874TZhC6oOSGUilvSyo4kVrnmlMm9QE62TwVRAt9uK9zf4DOY5yTHFpqxtUxGpS64lowfoLa8UfovLP4CVYmueQiHuNXGwC887Mhvl-bRZ8bnR9i4xv8FsCkJfiE31eNSYCdx-kD8GgGuGvxnQtgUzGyKavxyCe3dsEs4hk6anOC810-Re8P92_jp2Ly8vg8Hk0Ky4hMhZDQSiMNtVOhwNKGt5qZtuJEqYpONaWClNyqkjJbglVQiobLSghBFQDX1Sm63vquQvfZQ0z10kULi4Xx0PWxploTpoTSKqNXf9B51weff1eXhFW80rxkmSJbyoYuxgBtvQpuacJXTUm9OUP99wxZcrkz7qdLaH4E-6VnoNgC0czgd-q_ht_THYz0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2043539524</pqid></control><display><type>article</type><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><source>Access via SAGE</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Surjadi, Miranda</creator><creatorcontrib>Surjadi, Miranda</creatorcontrib><description>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</description><identifier>ISSN: 2165-0799</identifier><identifier>EISSN: 2165-0969</identifier><identifier>DOI: 10.1177/2165079917751479</identifier><identifier>PMID: 29359645</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Aged ; Antiviral Agents - pharmacology ; Antiviral drugs ; Centers for Disease Control and Prevention (U.S.) ; Disease control ; Employees ; Exposure ; Hepatitis ; Hepatitis C ; Hepatitis C, Chronic - diagnosis ; Hepatitis C, Chronic - therapy ; Humans ; Infectious diseases ; Mass Screening - statistics &amp; numerical data ; Medical personnel ; Middle Aged ; Needlestick injuries ; Nursing ; Occupational exposure ; Occupational Exposure - statistics &amp; numerical data ; Occupational health ; Occupational Health - statistics &amp; numerical data ; Practice Guidelines as Topic ; Risk ; Screening ; United States ; Viruses ; Workplaces</subject><ispartof>AAOHN journal, 2018-06, Vol.66 (6), p.302-309</ispartof><rights>2018 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</citedby><cites>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2165079917751479$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/2165079917751479$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29359645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Surjadi, Miranda</creatorcontrib><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><title>AAOHN journal</title><addtitle>Workplace Health Saf</addtitle><description>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</description><subject>Aged</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral drugs</subject><subject>Centers for Disease Control and Prevention (U.S.)</subject><subject>Disease control</subject><subject>Employees</subject><subject>Exposure</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C, Chronic - diagnosis</subject><subject>Hepatitis C, Chronic - therapy</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Mass Screening - statistics &amp; numerical data</subject><subject>Medical personnel</subject><subject>Middle Aged</subject><subject>Needlestick injuries</subject><subject>Nursing</subject><subject>Occupational exposure</subject><subject>Occupational Exposure - statistics &amp; numerical data</subject><subject>Occupational health</subject><subject>Occupational Health - statistics &amp; numerical data</subject><subject>Practice Guidelines as Topic</subject><subject>Risk</subject><subject>Screening</subject><subject>United States</subject><subject>Viruses</subject><subject>Workplaces</subject><issn>2165-0799</issn><issn>2165-0969</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1LAzEQhoMoVtS7Jwl48dDVZDefx1I_oeBBPS9pdramtNmaZAv-e1PaKgjOZYbM874TZhC6oOSGUilvSyo4kVrnmlMm9QE62TwVRAt9uK9zf4DOY5yTHFpqxtUxGpS64lowfoLa8UfovLP4CVYmueQiHuNXGwC887Mhvl-bRZ8bnR9i4xv8FsCkJfiE31eNSYCdx-kD8GgGuGvxnQtgUzGyKavxyCe3dsEs4hk6anOC810-Re8P92_jp2Ly8vg8Hk0Ky4hMhZDQSiMNtVOhwNKGt5qZtuJEqYpONaWClNyqkjJbglVQiobLSghBFQDX1Sm63vquQvfZQ0z10kULi4Xx0PWxploTpoTSKqNXf9B51weff1eXhFW80rxkmSJbyoYuxgBtvQpuacJXTUm9OUP99wxZcrkz7qdLaH4E-6VnoNgC0czgd-q_ht_THYz0</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Surjadi, Miranda</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201806</creationdate><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><author>Surjadi, Miranda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral drugs</topic><topic>Centers for Disease Control and Prevention (U.S.)</topic><topic>Disease control</topic><topic>Employees</topic><topic>Exposure</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C, Chronic - diagnosis</topic><topic>Hepatitis C, Chronic - therapy</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Mass Screening - statistics &amp; numerical data</topic><topic>Medical personnel</topic><topic>Middle Aged</topic><topic>Needlestick injuries</topic><topic>Nursing</topic><topic>Occupational exposure</topic><topic>Occupational Exposure - statistics &amp; numerical data</topic><topic>Occupational health</topic><topic>Occupational Health - statistics &amp; numerical data</topic><topic>Practice Guidelines as Topic</topic><topic>Risk</topic><topic>Screening</topic><topic>United States</topic><topic>Viruses</topic><topic>Workplaces</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Surjadi, Miranda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>AAOHN journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Surjadi, Miranda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</atitle><jtitle>AAOHN journal</jtitle><addtitle>Workplace Health Saf</addtitle><date>2018-06</date><risdate>2018</risdate><volume>66</volume><issue>6</issue><spage>302</spage><epage>309</epage><pages>302-309</pages><issn>2165-0799</issn><eissn>2165-0969</eissn><abstract>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>29359645</pmid><doi>10.1177/2165079917751479</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2165-0799
ispartof AAOHN journal, 2018-06, Vol.66 (6), p.302-309
issn 2165-0799
2165-0969
language eng
recordid cdi_proquest_miscellaneous_1990486898
source Access via SAGE; MEDLINE; Alma/SFX Local Collection
subjects Aged
Antiviral Agents - pharmacology
Antiviral drugs
Centers for Disease Control and Prevention (U.S.)
Disease control
Employees
Exposure
Hepatitis
Hepatitis C
Hepatitis C, Chronic - diagnosis
Hepatitis C, Chronic - therapy
Humans
Infectious diseases
Mass Screening - statistics & numerical data
Medical personnel
Middle Aged
Needlestick injuries
Nursing
Occupational exposure
Occupational Exposure - statistics & numerical data
Occupational health
Occupational Health - statistics & numerical data
Practice Guidelines as Topic
Risk
Screening
United States
Viruses
Workplaces
title Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20Hepatitis%20C%20Screening,%20Evaluation,%20and%20Treatment%20Update%20in%20the%20Age%20of%20Direct-Acting%20Antivirals&rft.jtitle=AAOHN%20journal&rft.au=Surjadi,%20Miranda&rft.date=2018-06&rft.volume=66&rft.issue=6&rft.spage=302&rft.epage=309&rft.pages=302-309&rft.issn=2165-0799&rft.eissn=2165-0969&rft_id=info:doi/10.1177/2165079917751479&rft_dat=%3Cproquest_cross%3E2043539524%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2043539524&rft_id=info:pmid/29359645&rft_sage_id=10.1177_2165079917751479&rfr_iscdi=true